← FDA DRUG APPROVALS

FDA ANDA · ANDA202015

YAELA

Sponsor: NOVAST LABS

APPLICATION
ANDA202015
TYPE
ANDA
ORIGINAL APPROVAL
2014-11-19
LATEST ACTION
2023-10-24
ROUTE
ORAL-28
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

YAELAPrescription
DROSPIRENONE 3MG, ETHINYL ESTRADIOL 0.03MG · TABLET · ORAL-28

Approval history

2023-10-24Labeling · Supplement 7 · standardAP
2023-10-24Labeling · Supplement 1 · standardAP
2023-10-24Labeling · Supplement 8 · standardAP
2014-11-19OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →